Candida infection of the central nervous system following neurosurgery: a 12-year review

[1]  F. Fitzpatrick,et al.  Candida parapsilosis meningitis associated with Gliadel (BCNU) wafer implants , 2011, British journal of neurosurgery.

[2]  F. Sörgel,et al.  Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections , 2010, Clinical Microbiology Reviews.

[3]  Stacy A. Voils,et al.  Candida Meningitis Post Gliadel Wafer Placement Successfully Treated with Intrathecal and Intravenous Amphotericin B , 2010, The Annals of pharmacotherapy.

[4]  E. Anaissie,et al.  Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  J. Sobel,et al.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  D. Andes,et al.  CNS pharmacokinetics of antifungal agents. , 2007, Expert opinion on drug metabolism & toxicology.

[7]  W. Hall,et al.  Postoperative central nervous system infection: incidence and associated factors in 2111 neurosurgical procedures. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  C.-H. Lu,et al.  Coagulase-Negative Staphylococcal Meningitis in Adults: Clinical Characteristics and Therapeutic Outcomes , 2005, Infection.

[9]  R. Wenzel,et al.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  R. Darouiche,et al.  Candida Infections of Medical Devices , 2004, Clinical Microbiology Reviews.

[11]  J. Bartlett.  Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study , 2004 .

[12]  P. Brennan,et al.  Risk factors for postcraniotomy surgical site infection after 1,3-bis (2-chloroethyl)-1-nitrosourea (Gliadel) wafer placement. , 2003, Clinical Infectious Diseases.

[13]  Á. Montero,et al.  Candida Infection of Cerebrospinal Fluid Shunt Devices: Report of Two Cases and Review of the Literature , 2000, Acta Neurochirurgica.

[14]  S. Gordon,et al.  Clinical significance of Candida species isolated from cerebrospinal fluid following neurosurgery. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  V. Yu,et al.  Meningitis caused by Candida species: an emerging problem in neurosurgical patients. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  R. M. Tucker,et al.  Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis , 1988, Antimicrobial Agents and Chemotherapy.

[17]  E. Block,et al.  Pharmacological Studies with 5-Fluorocytosine , 1972, Antimicrobial Agents and Chemotherapy.